Pneumococcal Polysaccharide Vaccine (PPSV23) (Nursing)

by Rhonda Lawes, PhD, RN

My Notes
  • Required.
Save Cancel
    Learning Material 4
    • PDF
      Slides Nursing Influenza and Pneumococcal Vaccination.pdf
    • PDF
      Review Sheet Adult Only Vaccines Nursing.pdf
    • PDF
      Reference List Medical Surgical Nursing and Pathophysiology Nursing.pdf
    • PDF
      Download Lecture Overview
    Report mistake

    00:01 Now let's talk about the pneumococcal polysaccharide vaccine.

    00:05 Doctors give a single dose of this vaccine to people who need it.

    00:09 There are some additional recommendations from the CDC for people with chronic medical conditions.

    00:16 Now, I've got a whole list for you there, but I know you're pretty familiar with what chronic medical conditions are.

    00:22 But no, generally doctors give a single dose.

    00:26 But if the patient has a chronic medical condition like we have listed there for you, they may need an additional one or two more doses.

    00:35 I know I'm giving you lots of information but take a look at this, the pneumococcal polysaccharide vaccine actually helps protect against twenty three types of pneumococcal bacteria.

    00:48 Now look back in your notes at the conjugate vaccine.

    00:51 Is this more or less than the conjugate vaccine? You got it. It's more.

    00:58 Now it doesn't come without side effects.

    01:00 They'll have some mild problems following a pneumococcal polysaccharide vaccination.

    01:05 So we're looking for reactions where the site was given some redness, some pain, but this should be mild.

    01:12 The patient can also develop fever or aching muscles.

    01:16 These problems should be fairly mild and go away within about two days.

    01:20 If they persist, the patient needs to contact their health care provider.

    01:26 Wow, I hate to even get into this topic.

    01:28 But remember, the point of this video is to educate you so you can make an informed decision.

    01:34 So we're going to talk about it because we have to.

    01:37 We're talking about the effectiveness of vaccines.

    01:40 Now, I'm not going to deal an opinion because I know there are plenty of them out there, okay? So I'm going to deal with numbers from the research studies from the CDC.

    01:51 So studies show that for each patient who received one dose of pneumococcal conjugate vaccine, here's what we see as far as impacting people developing that type of infection.

    02:03 80% fewer babies will develop pneumococcal infection.

    02:07 75% fewer patients aged 65 years or older will contract invasive pneumococcal disease.

    02:15 And 45 percent fewer patients who are 65 years or older will contract pneumococcal pneumonia.

    02:23 So pause for just a minute.

    02:25 I don't think you want to memorize these numbers but those are some pretty amazing statistics of how much lower the infection rate can be from this particular vaccine.

    02:37 Now, let's look at the pneumococcal polysaccharide vaccine, same thing, one dose, between 50 to 85% of a healthy adults will not develop invasive pneumococcal disease if they received the pneumococcal polysaccharide vaccine.

    About the Lecture

    The lecture Pneumococcal Polysaccharide Vaccine (PPSV23) (Nursing) by Rhonda Lawes, PhD, RN is from the course Influenza and Pneumococcal Vaccination (Nursing).

    Included Quiz Questions

    1. Those with chronic conditions should receive additional doses
    2. It protects against 13 types of pneumococcal bacteria
    3. Everyone receives at least 2 doses of vaccine
    4. Reactions to the vaccine should go away within a week

    Author of lecture Pneumococcal Polysaccharide Vaccine (PPSV23) (Nursing)

     Rhonda Lawes, PhD, RN

    Rhonda Lawes, PhD, RN

    Customer reviews

    5,0 of 5 stars
    5 Stars
    4 Stars
    3 Stars
    2 Stars
    1  Star